Although the peritoneum and abdominalcavity have an impaired blood supply, resulting in systemic therapy having limited efficacy, it has been demonstrated that 5-FU administered intravenously penetrates rapidly intoheated tumour nodules during HIPEC. The simultaneous administration of intravenous and intraperitoneal chemotherapy creates an ideal situation for enhancement of cytotoxicity in the heated tumour nodules